Document is current
Any future updates will be listed below
-
Authors
Radich, Jerald P.
Hochhaus, Andreas
Masszi, Tamás https://orcid.org/0000-0003-2322-9863
Hellmann, Andrzej
Stentoft, Jesper
Casares, María Teresa Gómez
García-Gutiérrez, J. Valentín https://orcid.org/0000-0003-4752-0815
Conneally, Eibhlin
le Coutre, Philipp D.
Gattermann, Norbert
Martino, Bruno
Saussele, Susanne https://orcid.org/0000-0003-0357-5785
Giles, Francis J.
Ross, David M. https://orcid.org/0000-0001-7171-2935
Aimone, Paola
Li, Sai
Titorenko, Ksenia https://orcid.org/0000-0002-5379-388X
Saglio, Giuseppe https://orcid.org/0000-0002-1046-3514
-
Funding
Funding for this research was provided by:
Novartis
- License Information
-
More Information
Article History
Received: 17 November 2020
Revised: 1 February 2021
Accepted: 18 February 2021
First Online: 11 March 2021
Compliance with ethical standards
:
: JPR has received research funding from Novartis and provided consulting to Novartis, Amgen, Bristol-Myers Squibb, and Jazz. AHo has received research funding from Novartis, Bristol-Myers Squibb, Incyte, MSD, and Pfizer, and honoraria from Bristol-Myers Squibb, Novartis, Pfizer, and Takeda. TM has participated in advisory board meetings for AbbVie, Bristol-Myers Squibb, Janssen, Novartis, Pfizer, and Takeda. JVGG has received honoraria and research funding and has provided consulting to Novartis, Bristol-Myers Squibb, Incyte, and Pfizer. EC has received research funding from and provided consulting to Novartis and received honoraria from Bristol-Myers Squibb, Gilead, and Pfizer. PDLC has received honoraria from Novartis, Incyte, and Pfizer. NG has received research funding, lecture honoraria, and travel support from Novartis. SS has received research funding and honoraria from Novartis, Bristol-Myers Squibb, and Incyte, and honoraria from Pfizer. FJG has received research funding from Novartis and Pfizer, and provided consulting to Novartis and Actuate Therapeutics Inc. DMR has received research funding and honoraria from and participated in advisory boards for Novartis and received honoraria from Bristol-Myers Squibb and research funding from Celgene. GS has received research funding from Novartis, Ariad, Bristol-Myers Squibb, Incyte, Pfizer, and Roche. PA, SL, and KT are employed by Novartis. AHe, JS, MTGC, and BM declare that they have no conflicts of interest. This study was sponsored and funded by Novartis Pharmaceuticals.
